NPIL Pharma is adding a sixth high potency substances production suite for manufacturing antibody drug conjugates at its Grangemouth, Scotland facility. The $270,000 cGMP facility has a capacity of 50kg/year and is due on stream in Q1 2008.
NPIL Pharma
Wednesday 30 January 2008
NPIL adds high potency suite
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment